16-10183567-GACACACACACACACACAC-GACACACACACACACACACACACACACACAC

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The ENST00000784515.1(ENSG00000302122):​n.209+1867_209+1868insACACACACACAC variant causes a intron change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.078 ( 606 hom., cov: 0)
Failed GnomAD Quality Control

Consequence

ENSG00000302122
ENST00000784515.1 intron

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.32

Publications

9 publications found
Variant links:
Genes affected
GRIN2A (HGNC:4585): (glutamate ionotropic receptor NMDA type subunit 2A) This gene encodes a member of the glutamate-gated ion channel protein family. The encoded protein is an N-methyl-D-aspartate (NMDA) receptor subunit. NMDA receptors are both ligand-gated and voltage-dependent, and are involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. These receptors are permeable to calcium ions, and activation results in a calcium influx into post-synaptic cells, which results in the activation of several signaling cascades. Disruption of this gene is associated with focal epilepsy and speech disorder with or without cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
GRIN2A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Landau-Kleffner syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • continuous spikes and waves during sleep
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • rolandic epilepsy-speech dyspraxia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • self-limited epilepsy with centrotemporal spikes
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000302122ENST00000784515.1 linkn.209+1867_209+1868insACACACACACAC intron_variant Intron 1 of 2
ENSG00000302122ENST00000784516.1 linkn.209+1867_209+1868insACACACACACAC intron_variant Intron 1 of 1
ENSG00000302122ENST00000784517.1 linkn.208+1867_208+1868insACACACACACAC intron_variant Intron 1 of 2
GRIN2AENST00000675398.2 linkc.-1124_-1123insGTGTGTGTGTGT upstream_gene_variant ENSP00000502752.1 A0A6Q8PHM7

Frequencies

GnomAD3 genomes
AF:
0.0781
AC:
9794
AN:
125334
Hom.:
605
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0357
Gnomad AMI
AF:
0.00498
Gnomad AMR
AF:
0.121
Gnomad ASJ
AF:
0.102
Gnomad EAS
AF:
0.111
Gnomad SAS
AF:
0.0957
Gnomad FIN
AF:
0.0805
Gnomad MID
AF:
0.0586
Gnomad NFE
AF:
0.0884
Gnomad OTH
AF:
0.0747
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0781
AC:
9797
AN:
125396
Hom.:
606
Cov.:
0
AF XY:
0.0796
AC XY:
4724
AN XY:
59354
show subpopulations
African (AFR)
AF:
0.0357
AC:
1159
AN:
32440
American (AMR)
AF:
0.121
AC:
1550
AN:
12764
Ashkenazi Jewish (ASJ)
AF:
0.102
AC:
325
AN:
3188
East Asian (EAS)
AF:
0.110
AC:
445
AN:
4042
South Asian (SAS)
AF:
0.0959
AC:
315
AN:
3286
European-Finnish (FIN)
AF:
0.0805
AC:
564
AN:
7008
Middle Eastern (MID)
AF:
0.0593
AC:
14
AN:
236
European-Non Finnish (NFE)
AF:
0.0884
AC:
5295
AN:
59932
Other (OTH)
AF:
0.0743
AC:
126
AN:
1696
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
377
755
1132
1510
1887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0832
Hom.:
154

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3219790; hg19: chr16-10277424; API